{
  "id": "f9519720fa263d8e",
  "title": "FDA Issues CRL to Anaphylm , Sublingual Film Formulation of Dibutepinephrine",
  "description": "20260202T203000Z",
  "content": "",
  "source": "pharmacytimes.com",
  "source_url": "https://www.pharmacytimes.com/view/fda-issues-crl-to-anaphylm-sublingual-film-formulation-of-dibutepinephrine",
  "published_at": "20260202T203000Z",
  "fetched_at": "2026-02-03T00:29:56.519436+00:00",
  "category": "health_biotech",
  "subcategory": null,
  "keywords": [
    "fda"
  ],
  "location": "United States",
  "raw_data": {
    "url": "https://www.pharmacytimes.com/view/fda-issues-crl-to-anaphylm-sublingual-film-formulation-of-dibutepinephrine",
    "url_mobile": "",
    "title": "FDA Issues CRL to Anaphylm , Sublingual Film Formulation of Dibutepinephrine",
    "seendate": "20260202T203000Z",
    "socialimage": "https://cdn.sanity.io/images/0vv8moc6/pharmacytimes/898d1a9830859b67c077238d16406b3d410630c0-5760x3840.jpg",
    "domain": "pharmacytimes.com",
    "language": "English",
    "sourcecountry": "United States"
  }
}